{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:59:55Z","timestamp":1790402395258,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3P0191"],"award-info":[{"award-number":["CMRPG3P0191"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3P0051~2"],"award-info":[{"award-number":["CMRPG3P0051~2"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-182A-040"],"award-info":[{"award-number":["NSTC 113-2314-B-182A-040"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10384-026-01390-9","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:43:54Z","timestamp":1783068234000},"page":"1287-1295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and treatment trends of retinopathy of prematurity: a multi-center study involving four Asian centers and one European center (2016\u20132023)"],"prefix":"10.1007","volume":"70","author":[{"given":"Yi-Hsuan","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas Ranjan","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvik","family":"Bhunia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan","family":"Seshasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Shih-Hsiang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Siew-Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal Kavalloor","family":"Visruthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie Hong Yee","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin Yan Grace","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Sze-wan","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Maria Pereira","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas Reis","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Yu-Chuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"1390_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/archdischild-2016-310532","volume":"102","author":"AL Solebo","year":"2017","unstructured":"Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017;102:853\u20137.","journal-title":"Arch Dis Child"},{"issue":"Suppl 1","key":"1390_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1):35\u201349.","journal-title":"Pediatr Res"},{"key":"1390_CR3","doi-asserted-by":"publisher","first-page":"15602","DOI":"10.1038\/s41598-023-42432-3","volume":"13","author":"YA Youn","year":"2023","unstructured":"Youn YA, Kim SY, Cho SJ, Chang YS, Miyake F, Kusuda S, et al. Variations in medical practice of retinopathy of prematurity among 8 Asian countries from an international survey. Sci Rep. 2023;13:15602.","journal-title":"Sci Rep"},{"key":"1390_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101018","volume":"88","author":"AS Tsai","year":"2022","unstructured":"Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E, et al. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res. 2022;88:101018.","journal-title":"Prog Retin Eye Res"},{"key":"1390_CR5","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1167\/iovs.18-24020","volume":"59","author":"EY Kang","year":"2018","unstructured":"Kang EY, Lien R, Wang NK, Lai CC, Chen KJ, Hwang YS, et al. Retinopathy of prematurity trends in Taiwan: a 10-year nationwide population study. Invest Ophthalmol Vis Sci. 2018;59:3599\u2013607.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1390_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603\u201315.","journal-title":"N Engl J Med"},{"key":"1390_CR7","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Group ETFROPC","year":"2003","unstructured":"Group ETFROPC. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684\u201394.","journal-title":"Arch Ophthalmol"},{"key":"1390_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1001\/jama.2022.10564","volume":"328","author":"A Stahl","year":"2022","unstructured":"Stahl A, Sukgen EA, Wu WC, Lepore D, Nakanishi H, Mazela J, et al. Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial. JAMA. 2022;328:348\u201359.","journal-title":"JAMA"},{"key":"1390_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","volume":"394","author":"A Stahl","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. The Lancet. 2019;394:1551\u20139.","journal-title":"The Lancet"},{"key":"1390_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13052-023-01543-3","volume":"49","author":"J Chen","year":"2023","unstructured":"Chen J, Hao Q, Zhang J, Du Y, Chen H, Cheng X. The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis. Ital J Pediatr. 2023;49:136.","journal-title":"Ital J Pediatr"},{"key":"1390_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ajo.2025.09.050","volume":"281","author":"TT Lai","year":"2026","unstructured":"Lai TT, Chen YC, Chi SC, Ho MM, Hsia NY, Chen SN, et al. Management of retinopathy of prematurity in the anti-VEGF era: consensus and recommendations from the Taiwan pediatric retina (TPR) group. Am J Ophthalmol. 2026;281:502\u201315.","journal-title":"Am J Ophthalmol"},{"key":"1390_CR12","unstructured":"Henriques G, Brito C, Teixeira S (2014). Consenso cl\u00ednico: retinopatia da prematuridade. se\u00e7\u00e3o de neonatologia, sociedade Portuguesa de pediatria Lisboa: Sociedade portuguesa de pediatria. 1\u201312. (in Portuguese)"},{"key":"1390_CR13","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.4103\/ijo.IJO_1827_19","volume":"68","author":"R Shukla","year":"2020","unstructured":"Shukla R, Murthy GVS, Gilbert C, Vidyadhar B, Mukpalkar S. Operational guidelines for ROP in India: a summary. Indian J Ophthalmol. 2020;68:S108\u201314.","journal-title":"Indian J Ophthalmol"},{"key":"1390_CR14","first-page":"54","volume":"38","author":"SW Leo","year":"1997","unstructured":"Leo SW, Cheong PY. Incidence of retinopathy of prematurity in Singapore. Singapore Med J. 1997;38:54\u20137.","journal-title":"Singapore Med J"},{"key":"1390_CR15","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/eye.2008.128","volume":"23","author":"AR Wilkinson","year":"2009","unstructured":"Wilkinson AR, Haines L, Head K, Fielder AR. UK retinopathy of prematurity guideline. Eye (Lond). 2009;23:2137\u20139.","journal-title":"Eye (Lond)"},{"key":"1390_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"Prematurity ICftCoRo","year":"2005","unstructured":"Prematurity ICftCoRo. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"1390_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/jpc.16699","volume":"61","author":"KW Teoh","year":"2025","unstructured":"Teoh KW, Seshasai S, Tan MGS, Ng WY, Shah VA, Ngeow AJH. Application of WINROP to predict severe retinopathy of prematurity in a multi-ethnic cohort in Singapore. J Paediatr Child Health. 2025;61:26\u201331.","journal-title":"J Paediatr Child Health"},{"key":"1390_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamaophthalmol.2023.0809","volume":"141","author":"A Bhatnagar","year":"2023","unstructured":"Bhatnagar A, Skrehot HC, Bhatt A, Herce H, Weng CY. Epidemiology of retinopathy of prematurity in the US From 2003 to 2019. JAMA Ophthalmol. 2023;141:479\u201385.","journal-title":"JAMA Ophthalmol"},{"key":"1390_CR19","unstructured":"Immigration & checkpoints authority (Singapore). Statistics. Immigration & checkpoints authority, Singapore. 2025. https:\/\/www.ica.gov.sg\/news-and-publications\/statistics. Accessed Feb 9 2025"},{"key":"1390_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.pedneo.2022.12.016","volume":"64","author":"J Lee","year":"2023","unstructured":"Lee J, Lee CYM, Naiduvaje K, Wong Y, Bhatia A, Ereno IL, et al. Trends in neonatal mortality and morbidity in very-low-birth-weight (VLBW) infants over a decade: Singapore national cohort study. Pediatr Neonatol. 2023;64:585\u201395.","journal-title":"Pediatr Neonatol"},{"key":"1390_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.11622\/smedj.2019095","volume":"61","author":"TR Ng","year":"2020","unstructured":"Ng TR, Wong IB, Ngo CS, Niduvaje K, Ngiam XY, Sensaki S, et al. Case control study of risk factors and ophthalmological outcomes of very low birth weight infants with Type 1 retinopathy of prematurity. Singapore Med J. 2020;61:426\u201334.","journal-title":"Singapore Med J"},{"key":"1390_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/APO.0000000000000313","volume":"9","author":"R Azad","year":"2020","unstructured":"Azad R, Gilbert C, Gangwe AB, Zhao P, Wu W-C, Sarbajna P, et al. Retinopathy of prematurity: how to prevent the third epidemics in developing countries. Asia Pac J Ophthalmol (Phila). 2020;9:440\u20138.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"1390_CR23","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1097\/IAE.0000000000002684","volume":"40","author":"EY Kang","year":"2020","unstructured":"Kang EY, Hsu KH, Chu SM, Lien R, Wang NK, Lai CC, et al. Ten-year epidemiology of retinopathy of prematurity treatment in Taiwan. Retina. 2020;40:1804\u201311.","journal-title":"Retina"},{"key":"1390_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2022-001166","author":"JH Jang","year":"2023","unstructured":"Jang JH, Kang YK, Park HS, Kim K, Kim SS, Han JY, et al. Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity. BMJ Open Ophthalmol. 2023. https:\/\/doi.org\/10.1136\/bmjophth-2022-001166.","journal-title":"BMJ Open Ophthalmol"},{"key":"1390_CR25","volume":"11","author":"M Fevereiro-Martins","year":"2024","unstructured":"Fevereiro-Martins M, Santos AC, Marques-Neves C, Bicho M, Guimar\u00e3es H, On Behalf Of The Gen ERSG. Retinopathy of prematurity in eight portuguese neonatal intensive care units: incidence, risk factors, and progression-a prospective multicenter study. Children (Basel). 2024;11:1154.","journal-title":"Children (Basel)"},{"key":"1390_CR26","first-page":"41","volume":"23","author":"LP Iu","year":"2017","unstructured":"Iu LP, Lai CH, Fan MC, Wong IY, Lai JS. Screening for retinopathy of prematurity and treatment outcome in a tertiary hospital in Hong Kong. Hong Kong Med J. 2017;23:41\u20137.","journal-title":"Hong Kong Med J"},{"key":"1390_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2147\/IJGM.S401122","volume":"16","author":"L BujoreanuBezman","year":"2023","unstructured":"BujoreanuBezman L, Tiutiuca C, Totolici G, Carneciu N, Bujoreanu FC, Ciortea DA, et al. Latest trends in retinopathy of prematurity: research on risk factors, diagnostic methods and therapies. Int J Gen Med. 2023;16:937\u201349.","journal-title":"Int J Gen Med"},{"key":"1390_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00417-017-3878-4","volume":"256","author":"C-Y Huang","year":"2018","unstructured":"Huang C-Y, Lien R, Wang N-K, Chao A-N, Chen K-J, Chen T-L, et al. Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2018;256:479\u201387.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1390_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1055813","volume":"11","author":"S Diggikar","year":"2023","unstructured":"Diggikar S, Gurumoorthy P, Trif P, Mudura D, Nagesh NK, Galis R, et al. Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: a systematic review and meta-analysis. Front Pediatr. 2023;11:1055813.","journal-title":"Front Pediatr"},{"key":"1390_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09053-8","volume":"12","author":"JH Ahn","year":"2022","unstructured":"Ahn JH, Lee KM, Kim MJ, Park HK, Kim YJ, Ahn SJ, et al. Neurodevelopmental outcomes in very low birthweight infants with retinopathy of prematurity in a nationwide cohort study. Sci Rep. 2022;12:5053.","journal-title":"Sci Rep"},{"key":"1390_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000449530","volume":"236","author":"E Alyama\u00e7Sukgen","year":"2016","unstructured":"Alyama\u00e7Sukgen E, \u00c7\u00f6mez A, Ko\u00e7luk Y, Cevher S. The process of retinal vascularization after anti-vegf treatment in retinopathy of prematurity: a comparison study between ranibizumab and bevacizumab. Ophthalmologica. 2016;236:139\u201347.","journal-title":"Ophthalmologica"},{"key":"1390_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00417-018-4168-5","volume":"257","author":"EA Sukgen","year":"2019","unstructured":"Sukgen EA, Ko\u00e7luk Y. Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2019;257:49\u201355.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1390_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40272-020-00433-z","volume":"23","author":"A Lee","year":"2021","unstructured":"Lee A, Shirley M. Ranibizumab: a review in retinopathy of prematurity. Pediatr Drugs. 2021;23:111\u20137.","journal-title":"Pediatr Drugs"},{"key":"1390_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/09286586.2023.2251147","volume":"31","author":"A Vinekar","year":"2024","unstructured":"Vinekar A, Venkatesh R, Mangalesh S, Jayadev C, Shetty KB, Gilbert C. Reducing the impact of the COVID-19 pandemic on retinopathy of prematurity screening: successful strategies learnt from a multi-center tele-medicine program in India. Ophthalmic Epidemiol. 2024;31:291\u20138.","journal-title":"Ophthalmic Epidemiol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01390-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:19:22Z","timestamp":1790399962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01390-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01390-9","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y-H Tseng, None; T. R. Padhi, None; S. Bhunia, None; S. Seshasai, None; A. S-H Tsai, None; G. S-W Tan, None; N. K. Visruthan, None; C. H. Y. Lai, None; T. Y. G. Hui, None; R. S-w Yiu, None; S. M. P. Teixeira, None; T. R. d. Costa, None; P-L Wu, None; E. Y-C Kang, None; K-J Chen, None; N-K Wang, None; Y-S Hwang, None; C-C Lai, None; W-C Wu, None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}